Hospital
Barton Healthcare System
Barton Healthcare System was paid $10.76M by Medicaid between Jan 2018 and Dec 2024, across 201 billing codes. Its largest line is 0450, Emergency room services — 13% of everything it billed.
33Billing provider infoBARTON HEALTHCARE SYSTEM
SOUTH LAKE TAHOE, CA 96150
SOUTH LAKE TAHOE, CA 96150
33aNPI1003867565assigned 05/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.76M
24GClaims367,091
24DCodes billed201
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#175 of 410
Median peer was paid$6.90M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,407 | $1.55M | |
| 2019 | 49,525 | $1.35M | |
| 2020 | 39,268 | $1.13M | |
| 2021 | 51,662 | $1.54M | |
| 2022 | 56,330 | $1.86M | |
| 2023 | 57,393 | $1.94M | |
| 2024incomplete | 54,506 | $1.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 13% | 19,649 | 17,352 | $1.38M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.9% | 27,559 | 7,911 | $746K |
| 99199 | Unlisted special service, procedure or report | 5.2% | 9,462 | 7,846 | $555K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.8% | 2,053 | 2,002 | $513K |
| 80053 | Comprehensive metabolic panel | 3.4% | 22,321 | 19,868 | $369K |
| 0250 | 3.2% | 19,427 | 8,985 | $348K | |
| 97139 | 3.2% | 12,805 | 2,762 | $343K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.1% | 5,531 | 4,909 | $338K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 4,185 | 3,971 | $306K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 2,049 | 1,969 | $287K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.3% | 7,614 | 3,204 | $252K |
| 97750 | 2.2% | 4,418 | 2,991 | $237K |
189 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 21,818 | $228K |
| 99284 | Emergency room visit (serious) | 2.0% | 1,845 | $212K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 1,317 | $204K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 3,122 | $204K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 4,498 | $188K |
| 99283 | Emergency room visit (moderate) | 1.7% | 2,689 | $186K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.7% | 1,973 | $186K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 5,897 | $161K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 7,070 | $160K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 2,743 | $150K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 3,212 | $142K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 3,203 | $141K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.1% | 522 | $114K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 443 | $113K |
| 80061 | Lipid panel | 1.0% | 7,158 | $112K |
| 87631 | <1% | 1,543 | $107K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,010 | $86K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,456 | $85K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,306 | $84K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,792 | $77K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,019 | $75K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,496 | $74K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,722 | $73K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 806 | $71K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,318 | $69K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 4,173 | $68K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,939 | $63K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 764 | $55K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,374 | $54K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 156 | $54K |
| 85027 | <1% | 5,047 | $50K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,909 | $49K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,957 | $48K |
| 83690 | <1% | 4,605 | $47K | |
| 84484 | <1% | 3,605 | $46K | |
| 84439 | <1% | 3,276 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,065 | $42K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 105 | $38K |
| 86803 | <1% | 1,719 | $36K | |
| 86703 | <1% | 2,187 | $35K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 380 | $34K |
| 81003 | <1% | 9,019 | $31K | |
| 99285 | Emergency room visit (most serious) | <1% | 194 | $31K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 489 | $31K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 120 | $30K |
| 73564 | <1% | 915 | $29K | |
| 81025 | <1% | 2,991 | $27K | |
| 73030 | <1% | 769 | $26K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 54 | $25K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,278 | $25K |
| 97799 | <1% | 944 | $23K | |
| Z7502 | <1% | 812 | $23K | |
| 83735 | <1% | 2,153 | $21K | |
| 87186 | <1% | 1,608 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,969 | $18K |
| 73610 | <1% | 641 | $17K | |
| 87077 | <1% | 1,825 | $17K | |
| J3490 | Unclassified drugs | <1% | 1,464 | $16K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,577 | $16K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 209 | $16K |
| 83605 | <1% | 1,168 | $16K | |
| 85610 | <1% | 3,104 | $16K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 778 | $15K |
| 86140 | <1% | 2,015 | $15K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 345 | $15K |
| 97802 | <1% | 185 | $15K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 438 | $15K |
| 86592 | <1% | 1,974 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,066 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 603 | $14K |
| 84153 | <1% | 622 | $14K | |
| 83880 | <1% | 478 | $13K | |
| 86850 | <1% | 561 | $13K | |
| 73630 | <1% | 501 | $13K | |
| 73110 | <1% | 409 | $12K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 38 | $12K |
| 85730 | <1% | 1,340 | $11K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 32 | $11K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,218 | $11K |
| 85651 | <1% | 1,981 | $10K | |
| 86901 | <1% | 775 | $10K | |
| 82570 | <1% | 1,287 | $10K | |
| 73130 | <1% | 386 | $10K | |
| 72110 | <1% | 201 | $9K | |
| 87340 | <1% | 528 | $9K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,484 | $9K |
| A9270 | Non-covered item or service | <1% | 7,389 | $8K |
| 87070 | <1% | 621 | $8K | |
| 97803 | <1% | 127 | $8K | |
| 86900 | <1% | 699 | $7K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $7K |
| 80076 | <1% | 667 | $7K | |
| 0370 | <1% | 25 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 117 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 122 | $7K |
| 80305 | <1% | 408 | $6K | |
| 83540 | <1% | 728 | $6K | |
| 83550 | <1% | 616 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,369 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,241 | $6K |
| 82607 | <1% | 553 | $5K | |
| 82728 | <1% | 403 | $5K | |
| 90715 | <1% | 143 | $5K | |
| 76642 | <1% | 93 | $5K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 142 | $5K |
| Z7610 | <1% | 556 | $5K | |
| 93971 | <1% | 44 | $5K | |
| 83516 | <1% | 378 | $4K | |
| 0710 | <1% | 45 | $4K | |
| 73221 | <1% | 12 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 837 | $4K |
| 82043 | <1% | 484 | $4K | |
| 87428 | <1% | 56 | $4K | |
| 84403 | <1% | 159 | $4K | |
| 84702 | <1% | 361 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 552 | $3K |
| 86038 | <1% | 320 | $3K | |
| 29125 | <1% | 112 | $3K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 77 | $3K |
| 87040 | <1% | 150 | $3K | |
| 82746 | <1% | 147 | $3K | |
| 87220 | <1% | 382 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 349 | $3K |
| 97165 | <1% | 54 | $3K | |
| 84550 | <1% | 444 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 26 | $2K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 101 | $2K |
| 86480 | <1% | 52 | $2K | |
| 93017 | <1% | 37 | $2K | |
| 72100 | <1% | 83 | $2K | |
| 94726 | <1% | 25 | $2K | |
| 94729 | <1% | 26 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 43 | $2K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 185 | $2K |
| 80074 | <1% | 31 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 277 | $2K |
| 87210 | <1% | 293 | $2K | |
| 94060 | <1% | 27 | $2K | |
| 72128 | <1% | 12 | $2K | |
| 72050 | <1% | 42 | $2K | |
| 86762 | <1% | 90 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 18 | $2K |
| 84481 | <1% | 58 | $1K | |
| 86376 | <1% | 143 | $1K | |
| 82948 | <1% | 260 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 136 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $1K |
| 76775 | <1% | 25 | $1K | |
| 87486 | <1% | 26 | $1K | |
| 87581 | <1% | 26 | $1K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 77 | $1K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 190 | $975.08 |
| 87807 | <1% | 93 | $962.68 | |
| 85379 | <1% | 76 | $954.38 | |
| 87081 | <1% | 100 | $928.11 | |
| 87430 | <1% | 64 | $895.77 | |
| 84402 | <1% | 40 | $840.08 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 18 | $785.20 |
| 86160 | <1% | 77 | $684.89 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 1,112 | $677.44 |
| 29515 | <1% | 34 | $646.07 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 16 | $606.82 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $589.29 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 22 | $554.18 |
| 81002 | <1% | 169 | $545.34 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 18 | $528.27 |
| 86787 | <1% | 82 | $506.00 | |
| 94760 | <1% | 60 | $414.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 58 | $402.93 |
| 72070 | <1% | 13 | $389.82 | |
| 86704 | <1% | 13 | $381.24 | |
| 86235 | <1% | 19 | $335.29 | |
| 86141 | <1% | 29 | $319.39 | |
| 0258 | <1% | 286 | $288.35 | |
| 97161 | <1% | 27 | $279.28 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 49 | $278.24 |
| 86677 | <1% | 13 | $255.18 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $254.16 |
| 0270 | <1% | 28 | $237.79 | |
| 82784 | <1% | 29 | $222.17 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 19 | $200.45 |
| 86706 | <1% | 13 | $185.57 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 20 | $111.42 |
| 84100 | <1% | 16 | $89.04 | |
| 86431 | <1% | 13 | $72.80 | |
| 82950 | <1% | 12 | $68.70 | |
| 87205 | <1% | 13 | $62.41 | |
| 96376 | <1% | 107 | $35.71 | |
| 80050 | General health panel | 0% | 126 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPURVANCE, CLINTON (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Barton Healthcare System | South Lake Tahoe, CA | $22.66M |
| Barton Healthcare System | South Lake Tahoe, CA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.